| Secondary |
| Product Used For Unknown Indication |
41.3% |
| Drug Use For Unknown Indication |
22.8% |
| Myocardial Infarction |
6.5% |
| Atrial Fibrillation |
4.3% |
| Diabetes Mellitus |
4.3% |
| Infection |
4.3% |
| Prophylaxis |
4.3% |
| Trigeminal Neuralgia |
4.3% |
| Acute Myocardial Infarction |
2.2% |
| Secondary Prevention |
2.2% |
| Angina Pectoris |
1.1% |
| Hypercholesterolaemia |
1.1% |
| Thrombosis Prophylaxis |
1.1% |
|
| Angioedema |
20.8% |
| Dyspnoea Exertional |
20.8% |
| Libido Decreased |
8.3% |
| Myocardial Infarction |
8.3% |
| Trigeminal Neuralgia |
8.3% |
| Vertigo |
8.3% |
| Atrioventricular Block |
4.2% |
| Dyspnoea |
4.2% |
| Epistaxis |
4.2% |
| Gastrointestinal Haemorrhage |
4.2% |
| Myocarditis |
4.2% |
| Toxic Epidermal Necrolysis |
4.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
20.5% |
| Hypertension |
14.8% |
| Atrial Fibrillation |
6.8% |
| Drug Use For Unknown Indication |
6.8% |
| Myocardial Ischaemia |
5.0% |
| Hypercholesterolaemia |
4.8% |
| Pain |
4.4% |
| Renal Failure Chronic |
3.9% |
| Thrombosis Prophylaxis |
3.9% |
| Cardiac Failure |
3.7% |
| Constipation |
3.5% |
| Prophylaxis |
3.3% |
| Ill-defined Disorder |
2.8% |
| Diabetes Mellitus |
2.6% |
| Dyslipidaemia |
2.4% |
| Type 2 Diabetes Mellitus |
2.4% |
| Colorectal Cancer Metastatic |
2.2% |
| Multiple Myeloma |
2.2% |
| Cardiovascular Disorder |
2.0% |
| Hypothyroidism |
2.0% |
|
| Rhabdomyolysis |
14.3% |
| Tachycardia |
8.3% |
| Syncope |
7.1% |
| Vertigo |
7.1% |
| Vomiting |
6.0% |
| Death |
4.8% |
| Ejection Fraction Decreased |
4.8% |
| Urine Colour Abnormal |
4.8% |
| Aplasia Pure Red Cell |
3.6% |
| Dyspnoea |
3.6% |
| Epistaxis |
3.6% |
| Haemoglobin Decreased |
3.6% |
| Hypertransaminasaemia |
3.6% |
| Malaise |
3.6% |
| Melaena |
3.6% |
| Myalgia |
3.6% |
| Myocardial Ischaemia |
3.6% |
| Neutropenia |
3.6% |
| Oropharyngeal Pain |
3.6% |
| Platelet Count Decreased |
3.6% |
|
| Interacting |
| Myocardial Infarction |
62.5% |
| Drug Use For Unknown Indication |
20.8% |
| Trigeminal Neuralgia |
16.7% |
|
| Myocardial Infarction |
50.0% |
| Trigeminal Neuralgia |
50.0% |
|
